Point72 Asset Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Point72 Asset Management’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,465,420	Closed	-$157M	–	2948
2023 Q1	$157M	Buy	1,465,420 +199,337	+16%	+$22.9M	0.49%	34
2022 Q4	$139M	Buy	1,266,083 +673,187	+114%	+$43.7M	0.47%	33
2022 Q3	$35M	Sell	592,896 -773,530	-57%	-$35.4M	0.14%	193
2022 Q2	$38.6M	Buy	1,366,426 +1,316,426	+2,633%	+$38.2M	0.16%	172
2022 Q1	$1.89M	Sell	50,000 -84,537	-63%	-$3.34M	0.01%	883
2021 Q4	$5.32M	Sell	134,537 -601,865	-82%	-$18.8M	0.02%	650
2021 Q3	$17.5M	Sell	736,402 -27,700	-4%	-$654K	0.08%	348
2021 Q2	$18.8M	Sell	764,102 -35,898	-4%	-$801K	0.08%	297
2021 Q1	$14.6M	Buy	+800,000	New	+$16.5M	0.07%	336

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Point72 Asset Management's RXDX Position: Q2 2023 in Review

Point72 Asset Management sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 1,465,420 shares — an estimated $157M sold.

Point72 Asset Management first reported a position in RXDX in Q1 2021 and held it in 9 quarters. The position peaked at $157M in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Point72 Asset Management reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Point72 Asset Management sold 1,465,420 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $157M.
Point72 Asset Management first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
Point72 Asset Management's Prometheus Biosciences, Inc. Common Stock position peaked at $157M in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.